18 Results for "

Topotecan Hydrochloride

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "Topotecan Hydrochloride" in MCE Product Catalog:

40
40 Publications Verification
Cat. No.: HY-13768A
CAS No.: 119413-54-6
Purity:  99.89%
Synonyms: SKF 104864A Hydrochloride; NSC 609669 Hydrochloride
Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
loading...
    loading...
40
40 Publications Verification
Cat. No.: HY-13768
CAS No.: 123948-87-8
Synonyms: SKF 104864A; NSC 609669
Research Areas:  

Cancer

Topotecan (SKF 104864A; NSC 609669) is an orally active and potent Topoisomerase I inhibitor. Topotecan induces cell cycle arrest in G0/G1 and S phases and promotes apoptosis. Topotecan shows anticancer activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-125203
CAS No.: 1093793-05-5
Purity:  99.30%
Synonyms: NSC 744039
Research Areas:  

Cancer

PV-1019 (NSC 744039) is a potent, selective Chk2 inhibitor with an IC50 value of 24 nM. PV-1019 inhibits the Topotecan (HY-13768)-induced Chk2 autophosphorylation. PV-1019 inhibits IR-induced apoptosis .
loading...
    loading...
Cat. No.: HY-161853
CAS No.: 2446767-14-0
Research Areas:  

Others

TX-2552 is an orally active tyrosine DNA phosphodiesterase 1 (TDP1) inhibitor with an IC50 value of 0.62 μM. TX-2552 can enhance the clastogenic activity of Topotecan (HY-13768) in mouse bone marrow cells, as well as the anti-tumor effect of Topotecan (HY-13768) in Krebs-2 ascites tumor mice .
loading...
    loading...
Cat. No.: HY-161152
CAS No.: 2190506-29-5
Research Areas:  

Cancer

DNA relaxation-IN-1 (Compound 27) is a DNA ligase 1 DNA Lig1) inhibitor. DNA relaxation-IN-1 inhibits DNA ligation and disrupts the DNA relaxing activity of DNA Lig1. DNA relaxation-IN-1 induces Apoptosis. DNA relaxation-IN-1, in combination with Topotecan (HY-13768), exhibits synergistic antiproliferative effects against colorectal cancer .
loading...
    loading...
Cat. No.: HY-13768S1
CAS No.: 1044904-10-0
Topotecan-d6 is the deuterium labeled Topotecan. Topotecan (SKF 104864A; NSC 609669) is a Topoisomerase I inhibitor. The IC50 values of Topotecan at 24 h are 2.73±0.25 μM of U251 cells, 2.95±0.23 μM of U87 cells, 5.46±0.41 μM of GSCs-U251 and 5.95 μM of GSCs-U87 .
loading...
    loading...
Cat. No.: HY-132685AS
CAS No.: 2701830-42-2
N-Desmethyl Topotecan-d3 hydrochloride is the deuterium labeled N-Desmethyl Topotecan hydrochloride .
loading...
    loading...
Cat. No.: HY-132685S
CAS No.: 1217633-79-8
N-Desmethyl Topotecan-d3 is the deuterium labeled N-Desmethyl Topotecan .
loading...
    loading...
Cat. No.: HY-13768C
CAS No.: 1044663-62-8
Synonyms: SKF 104864A Hydrochloride hydrate; NSC 609669 Hydrochloride hydrate
Research Areas:  

Cancer

Topotecan hydrochloride hydrate is an orally active and potent Topoisomerase I inhibitor. Topotecan hydrochloride hydrate induces cell cycle arrest in G0/G1 and S phases and promotes apoptosis. Topotecan hydrochloride hydrate shows anticancer activity .
loading...
    loading...
Cat. No.: HY-13768AR
CAS No.: 119413-54-6
Synonyms: SKF 104864A Hydrochloride (Standard); NSC 609669 Hydrochloride (Standard)
Topotecan (hydrochloride) (Standard) is the analytical standard of Topotecan (hydrochloride). This product is intended for research and analytical applications. Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
loading...
    loading...
Cat. No.: HY-13768D
CAS No.: 123948-88-9
Synonyms: SKF 104864A acetate; NSC 609669 acetate
Target:  

Topoisomerase

Research Areas:  

Cancer

Topotecan acetate is a topoisomerase inhibitor.
loading...
    loading...
Cat. No.: HY-13768S
CAS No.: 1133355-98-2
Synonyms: SKF 104864A-d5; NSC 609669-d5
Topotecan-d5 is the deuterium labeled Topotecan. Topotecan (SKF 104864A; NSC 609669) is a Topoisomerase I inhibitor. The IC50 values of Topotecan at 24 h are 2.73±0.25 μM of U251 cells, 2.95±0.23 μM of U87 cells, 5.46±0.41 μM of GSCs-U251 and 5.95±0.24 μM of GSCs-U87 .
loading...
    loading...
Cat. No.: HY-W740425
Topotecan Carboxylic Acid Sodium Salt-d6 is the deuterium labeled Topotecan Carboxylic Acid Sodium Salt.
loading...
    loading...
Cat. No.: HY-W740426
CAS No.: 190710-79-3
Target:  

Drug Metabolite

Research Areas:  

Cancer

N-Desmethyltopotecan is a metabolite of Topotecan (HY-13768), and it can be detected in plasma, urine and feces .
loading...
    loading...
Cat. No.: HY-13768S2
Synonyms: SKF 104864A-d6 diHydrochloride; NSC 609669-d6 diHydrochloride
Topotecan-d6 dihydrochloride (SKF 104864A-d6 dihydrochloride) is the deuterium labeled Topotecan dihydrochloride. Topotecan (SKF 104864A; NSC 609669) is an orally active and potent Topoisomerase I inhibitor. Topotecan induces cell cycle arrest in G0/G1 and S phases and promotes apoptosis. Topotecan shows anticancer activity .
loading...
    loading...
Cat. No.: HY-121857
CAS No.: 66528-28-7
Target:  

BCRP

Research Areas:  

Cancer

NSC636795 is an inhibitor of the ABCG2 transporter. NSC636795 inhibits ABCG2-mediated PhA efflux. NSC636795 also partially reverses ABCG2-mediated resistance to Topotecan (HY-13768). NSC636795 can be used in studies related to ABCG2-mediated antitumor drug resistance .
loading...
    loading...
Cat. No.: HY-183546
TDP1-IN-6 is a TDP1 inhibitor with an IC50 of 1.52 μM. Combination of TDP1-IN-6 with Topotecan (HY-13768) enhances DNA damage, induces Apoptosis, triggers S-phase cell cycle arrest, and promotes Ferroptosis. TDP1-IN-6 can be used for the research of cervical cancer .
loading...
    loading...
Cat. No.: HY-187719
CAS No.: 318262-42-9
Target:  

Proton Pump Apoptosis

Research Areas:  

Cancer

NIK-12192 is an orally active inhibitor of vacuolar H +-ATPase. NIK-12192 reduces intracellular pH, decreases lysosomal volume and acidity, and alters the intracellular localization of V-ATPase by inhibiting proton pumps . NIK-12192 induces αvβ5 integrin polarization, cytoskeletal disruption, cell detachment, anoikis-mediated delayed apoptosis and necrosis, a delayed reduction in mitochondrial membrane potential, and lysosomal/phagosomal accumulation. NIK-12192 inhibits tumor cell migration, invasion, and three-dimensional spheroid growth, and enhances the activity of Topotecan (HY-13768). NIK-12192 suppresses spontaneous lung metastasis in vivo. NIK-12192 is used in research related to colon cancer, ovarian cancer, lung cancer, breast cancer, renal cancer, prostate cancer, acute myeloid leukemia, and melanoma .
loading...
    loading...
  • 1